Suppr超能文献

比较针对艾滋病毒感染者和阿片类药物使用障碍者的简短整体健康艾滋病毒(3H+)与整体健康康复计划(HHRP+):一项随机、对照非劣效性试验的结果。

Comparing the brief Holistic Health for HIV (3H+) to the Holistic Health Recovery Program (HHRP+) among people with HIV and opioid use disorder: Results from a randomized, controlled non-inferiority trial.

机构信息

Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, United States of America.

Ikerbasque Research Foundation, Bilbao, Spain.

出版信息

PLoS One. 2024 Nov 7;19(11):e0312165. doi: 10.1371/journal.pone.0312165. eCollection 2024.

Abstract

Few evidence-based interventions have been widely adopted in common clinical settings, particularly for opioid-dependent people with HIV (PWH) seeking drug treatment. We developed a brief evidence-based intervention, Holistic Health for HIV (3H+), specifically for ease of implementation and integration within drug treatment settings. In this study, we compared 3H+ to the gold standard, Holistic Health Recovery Program (HHRP+) using a non-inferiority trial. Between 2012 and 2017, 106 participants were randomly assigned to either the brief 3H+ intervention or the gold standard HHRP+. HIV treatment (ART adherence, viral suppression) and risk behaviors (sharing injection equipment, condom use) were compared between the two arms at baseline, end-of-intervention (EOI-12 weeks) and at follow-up (24 weeks). Average treatment effect was calculated based on the difference-in-difference (DID) estimator and a non-parametric bootstrap was used to assess non-inferiority. At the 12-week EOI point, 3H+ was found to be non-inferior to HHRP+ with respect to multiple outcomes: percent sharing syringes and needles (DID:1.4, 95%CI [-18.6,21.5], p<0.01) and attainment of high ART adherence (DID: 9.7, 95%CI: [-13.1, 32.2], p = 0.04). At the 24-week EOI point, 3H+ was found to be non-inferior to HHRP+ with respect to percent sharing syringes and needles (DID: 8.9, [-10.1, 28.30], p = 0.04) and attainment of viral suppression (DID: 18.9, 95% CI:[-7.1, 42.0], p = 0.01). For other indicators, such as consistent condom use, the hypothesis test for non-inferiority was inconclusive at the 12-week EOI (DID: -20.2, 95%CI [-48.9-10.7], p = 0.51). For HIV treatment as prevention to be effective, PWH need to achieve viral suppression. In the absence of this success, they must reduce HIV risk behaviors. The finding that 3H+ was non-inferior to HHRP+ suggests that brief behavioral interventions can be deployed in real world settings to help more efficiently achieve Ending the HIV Epidemic goals.

摘要

在常见的临床环境中,很少有循证干预措施被广泛采用,特别是对于寻求药物治疗的感染艾滋病毒的阿片类药物依赖者(PWH)。我们开发了一种简短的循证干预措施,即艾滋病毒综合健康(3H+),专门用于便于在药物治疗环境中实施和整合。在这项研究中,我们使用非劣效性试验将 3H+与黄金标准的综合健康康复方案(HHRP+)进行了比较。在 2012 年至 2017 年间,106 名参与者被随机分配到简短的 3H+干预组或黄金标准的 HHRP+组。在基线、干预结束时(12 周)和随访(24 周)时,比较了两组之间的艾滋病毒治疗(ART 依从性、病毒抑制)和风险行为(共用注射器具、使用避孕套)。基于差异(DID)估计值计算平均治疗效果,并使用非参数引导法评估非劣效性。在 12 周的干预结束时,发现 3H+在多个结果方面与 HHRP+不劣效:共用注射器和针头的百分比(DID:1.4,95%CI[-18.6,21.5],p<0.01)和实现高 ART 依从性(DID:9.7,95%CI:[-13.1,32.2],p=0.04)。在 24 周的干预结束时,发现 3H+在共用注射器和针头的百分比(DID:8.9,[-10.1,28.30],p=0.04)和实现病毒抑制方面与 HHRP+不劣效:达到病毒抑制(DID:18.9,95%CI:[-7.1,42.0],p=0.01)。对于其他指标,如坚持使用避孕套,在 12 周的干预结束时,非劣效性假设检验不确定(DID:-20.2,95%CI[-48.9-10.7],p=0.51)。为了使 HIV 治疗作为预防措施有效,PWH 需要实现病毒抑制。如果没有取得这一成功,他们必须减少艾滋病毒风险行为。发现 3H+与 HHRP+不劣效表明,简短的行为干预措施可以在现实环境中部署,以帮助更有效地实现终结艾滋病流行的目标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2788/11542883/8487232b8331/pone.0312165.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验